Duloxetine Dosing Recommendations for Chronic Pain Management

Indication-Specific Dosing

The National Comprehensive Cancer Network recommends duloxetine as a first-line coanalgesic for neuropathic pain, with a starting dose of 30-60 mg daily, which can be increased to 60-120 mg daily 1
The MMWR Recommendations and Reports guideline suggests that duloxetine is FDA-approved for diabetic peripheral neuropathy at 60 mg once daily 2
The MMWR Recommendations and Reports guideline also recommends duloxetine for neuropathic pain, with a starting dose of 30-60 mg daily, which can be increased to 60-120 mg daily 3, 2

The Journal of the National Comprehensive Cancer Network recommends using slower titration in geriatric patients due to increased sensitivity 1

The MMWR Recommendations and Reports guideline warns that discontinuation symptoms, including dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue, can occur if duloxetine is stopped abruptly, and recommends gradual dose reduction 3

The guideline recommendations for painful diabetic neuropathy suggest a dose of 60-120 mg/day, with 60 mg being the FDA-approved dose, according to the Diabetes/Metabolism Research and Reviews 4

For patients with disorders of gut-brain interaction, starting with 30 mg once daily and titrating according to response and tolerability to a maximum of 60 mg once daily minimizes common side effects, as reported in Clinical Gastroenterology and Hepatology 5, 6